Y-mAbs Therapeutics, Inc.

NASDAQ:YMAB

8.28 (USD) • At close December 20, 2024
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q1
Omzet 18.46122.79819.93123.36320.45420.75120.25131.44712.53710.79710.4869.5988.96510.9515.38320.75000000000000000
Kosten van de omzet 2.2483.0142.1472.0392.6454.6492.0832.022.4751.241.8311.4610.550.410.0932.203000000000000000
Brutowinst 16.21319.78417.78421.32417.80916.10218.16829.42710.0629.5578.6558.1378.41510.5415.2918.547000000000000000
Brutowinstmarge 0.8780.8680.8920.9130.8710.7760.8970.9360.8030.8850.8250.8480.9390.9630.9830.894000000000000000
Onderzoek- en ontwikkelingskosten 11.16812.34113.26713.38815.35812.05513.41819.78722.45326.4222.91228.75723.13119.77821.57924.01121.00530.05918.62216.82719.6614.49412.51111.0418.7318.2936.2046.6253.0762.3032.303
Algemene en administratieve kosten 00000000000000014.6311.63610.3938.1256.9314.6994.143.7423.0372.6841.9651.2752.650.7660.7610.761
Verkoop- en marketingkosten 0000000000000000000000000000000
Verkoop-, algemene en administratieve kosten 13.61317.23211.42511.13510.211.2712.25110.79313.62623.08213.43815.13813.98813.47511.9714.6311.63610.3938.1256.9314.6994.143.7423.0372.6841.9651.2752.650.7660.7610.761
Overige kosten 0-0.17000000.10000.210062.012.2030000000.3190-0.011000.0210.01500
Bedrijfskosten 24.78129.57324.69224.52325.55823.32525.66930.5836.07949.50236.3543.89537.11933.25333.54938.64132.64140.45226.74723.75824.35918.63416.25314.07811.41510.2587.4799.2753.8423.0413.041
Bedrijfsresultaat -8.568-9.789-6.908-3.199-7.749-7.223-7.501-1.153-26.017-39.945-27.695-35.758-28.704-22.712-28.259-20.094-32.641-40.452-26.747-23.758-24.359-18.634-16.253-14.078-11.415-10.258-7.479-9.275-3.842-3.064-3.064
Bedrijfsresultaat ratio -0.464-0.429-0.347-0.137-0.379-0.348-0.37-0.037-2.075-3.7-2.641-3.726-3.202-2.074-5.25-0.968000000000000000
Totaal overige inkomsten en kosten netto 1.9160.640.4392.4060.1891.11.1112.31-1.509-1.186-0.373-1.135-0.154-0.22561.6720.161-0.1910.0590.5680.6220.4370.5980.3190.018-0.011-0.047-0.0040.0210.0150.0230.023
Inkomen voor belasting -6.652-9.149-6.469-0.793-7.56-6.123-6.391.157-27.526-41.131-28.068-36.893-28.858-22.93733.413-19.933-32.832-40.393-26.179-23.136-23.922-18.036-15.934-14.06-11.426-10.305-7.483-9.254-3.827-3.041-3.041
Inkomen voor belasting ratio -0.36-0.401-0.325-0.034-0.37-0.295-0.3160.037-2.196-3.809-2.677-3.844-3.219-2.0956.207-0.961000000000000000
Belastingkosten 0.3460.10.160.1950.1870.179-1.2931.5581.5091.1860.3731.1350-0.2160.3382.086000-0.07900-0.019000-7.479-9.275-3.8420.0230.023
Nettowinst -6.998-9.249-6.629-0.988-7.747-6.302-5.097-0.401-29.035-42.317-28.441-36.893-28.858-22.93733.413-19.933-32.832-40.393-26.179-23.136-23.922-18.036-15.934-14.06-11.426-10.305-7.483-9.254-3.827-3.041-3.041
Nettowinstmarge -0.379-0.406-0.333-0.042-0.379-0.304-0.252-0.013-2.316-3.919-2.712-3.844-3.219-2.0956.207-0.961000000000000000
WPA (Winst Per Aandeel) -0.16-0.21-0.15-0.023-0.18-0.14-0.12-0.009-0.66-0.97-0.65-0.85-0.66-0.530.8-0.48-0.82-1.01-0.66-0.61-0.7-0.53-0.47-0.41-0.42-0.32-0.22-0.28-0.11-0.17-0.17
Verwaterde WPA -0.16-0.21-0.15-0.023-0.18-0.14-0.12-0.009-0.66-0.97-0.65-0.85-0.66-0.530.75-0.45-0.82-1.01-0.66-0.58-0.7-0.53-0.47-0.41-0.42-0.32-0.22-0.28-0.11-0.17-0.17
EBITDA -8.447-9.636-6.749-3.038-7.581-6.999-7.501-0.306-25.791-39.945-27.5-35.467-28.559-22.496-28.129-19.977-32.548-40.352-26.661-23.679-24.311-18.614-16.234-14.064-11.406-10.2520000.0230.023
EBITDA ratio -0.458-0.423-0.339-0.13-0.379-0.348-0.37-0.037-2.057-3.682-2.623-3.726-3.186-2.074-5.226-0.862000000000000000